Marjo's Blog

Empower, Inspire, and Transform: Your Path to Personal Growth

Hypothyroidism & Diabetes: New Treatments & Tips

Medication: The Cornerstone of Treatment

To treat hypothyroidism caused by Hashimoto's thyroiditis and diabetes, doctors primarily prescribe levothyroxine. Working closely with your doctor to determine the correct dosage to keep your thyroid hormone levels within the normal range is crucial. Managing diabetes may involve taking oral medications or insulin therapy, which doctors can modify based on blood sugar levels and other considerations[3].

Lifestyle Changes: A Key Component in Management

In addition to medication, lifestyle changes can help manage hypothyroidism and diabetes. It may include following a balanced diet low in refined sugars and carbohydrates, engaging in regular physical activity, and getting enough sleep[2][4].

Regular Monitoring: Essential for Optimal Health

Monitoring thyroid hormone levels, blood sugar levels, and other health markers is essential for managing hypothyroidism and diabetes. It may include regular blood tests, additional diagnostic tests, and regular check-ins with your doctor to discuss your symptoms and treatment plan[3].

Support: A Valuable Resource in Your Journey

Finally, having a support system in place can be helpful when managing these conditions. It may include working with a registered dietitian or diabetes educator, joining support groups or online forums, and staying informed about the latest research and treatment options[4].

New Therapies: Enhancing Treatment Strategies

  • Doctors still consider levothyroxine as the primary treatment for hypothyroidism caused by Hashimoto's thyroiditis and diabetes. However, they may contemplate administering a combination of levothyroxine and liothyronine for patients who are unresponsive to levothyroxine treatment. According to a study published in the Journal of Diabetes Research, patients receiving combination therapy showed improved glycaemic control and reduced insulin resistance compared to those receiving levothyroxine alone[1].
  • Anti-TNF-alpha agents, specifically biologics, represent another possible therapy for treating autoimmune thyroid diseases, such as Hashimoto's thyroiditis. A study published in the Journal of Endocrinology and Metabolism discovered that patients with autoimmune thyroid disorders had a greater incidence of insulin resistance and metabolic syndrome. Anti-TNF-alpha agents have effectively improved insulin resistance and glycaemic control in rheumatoid arthritis patients. They could have a comparable impact on individuals with autoimmune thyroid disease[1].

Current Clinical Trials: Investigating Novel Approaches

Researchers are performing a phase 2 clinical trial to evaluate the safety and effectiveness of a novel drug, Sotatercept, in treating hypothyroidism caused by Hashimoto's thyroiditis and type 2 diabetes. Sotatercept is a fusion protein that targets the activin receptor signalling pathway, which regulates thyroid hormone[1].

Promising Developments: Exploring the Gut Microbiota Connection

Studies have demonstrated a potential association between gut microbiota and autoimmune thyroid disorders. According to research published in the Journal of Clinical Endocrinology and Metabolism, patients with Hashimoto's thyroiditis exhibited a different gut microbiota composition than healthy controls. Modifying the intestinal microbiota has been revealed to enhance insulin resistance and glycaemic power in type 2 diabetes patients[1].